Biofrontera BFRI Stock
$1.50
2.746574%
Add to favorites
SECTOR
COUNTRY
Exchange
Market Cap
$22.28M
LOW - HIGH [24H]
$1.42
-
$1.52
VOLUME [24H]
$385.41K
P/E Ratio
0
Earnings per share
-$0.43
ISIN
US09077D2099
Biofrontera Price Chart
Biofrontera BFRI Financial and Trading Overview
| Biofrontera stock price | 1.5 USD |
| Previous Close | 1.48 USD |
| Open | 1.48 USD |
| Bid | 1.08 USD x 100 |
| Ask | 1.81 USD x 100 |
| Day's Range | 1.41 - 1.55 USD |
| 52 Week Range | 0.56 - 1.55 USD |
| Volume | 983.96K USD |
| Avg. Volume | 377.59K USD |
| Market Cap | 21.68M USD |
| Beta (5Y Monthly) | 0.798 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.43 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 6 USD |
BFRI Valuation Measures
| Enterprise Value | 24.52M USD |
| Trailing P/E | N/A |
| Forward P/E | 3.3953488 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.4696144 |
| Price/Book (mrq) | 3.484487 |
| Enterprise Value/Revenue | 0.531 |
| Enterprise Value/EBITDA | -4.109 |
Trading Information
Biofrontera Stock Price History
| Beta (5Y Monthly) | 0.798 |
| 52-Week Change | 62.22% |
| S&P500 52-Week Change | 18.35% |
| 52 Week High | 1.55 USD |
| 52 Week Low | 0.56 USD |
| 50-Day Moving Average | 1.14 USD |
| 200-Day Moving Average | 0.96 USD |
BFRI Share Statistics
| Avg. Volume (3 month) | 377.59K USD |
| Avg. Daily Volume (10-Days) | 714.82K USD |
| Shares Outstanding | 14.85M |
| Float | 11.84M |
| Short Ratio | 0.15 |
| % Held by Insiders | 11.99% |
| % Held by Institutions | 20.71% |
| Shares Short | 61.08K |
| Short % of Float | 0.50% |
| Short % of Shares Outstanding | 0.47% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -13.78% |
| Operating Margin (ttm) | -4.36% |
| Gross Margin | 79.25% |
| EBITDA Margin | -12.92% |
Management Effectiveness
| Return on Assets (ttm) | -17.44% |
| Return on Equity (ttm) | -988.35% |
Income Statement
| Revenue (ttm) | 46.18M USD |
| Revenue Per Share (ttm) | 3.92 USD |
| Quarterly Revenue Growth (yoy) | 32.89% |
| Gross Profit (ttm) | 36.6M USD |
| EBITDA | -5968000 USD |
| Net Income Avi to Common (ttm) | -6365000 USD |
| Diluted EPS (ttm) | -0.43 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 4.67M USD |
| Total Cash Per Share (mrq) | 0.31 USD |
| Total Debt (mrq) | 7.5M USD |
| Total Debt/Equity (mrq) | 125.99 USD |
| Current Ratio (mrq) | 1.18 |
| Book Value Per Share (mrq) | 0.419 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -7927000 USD |
| Levered Free Cash Flow (ttm) | -7597750 USD |
Profile of Biofrontera
| Country | United States |
| State | MA |
| City | Woburn |
| Address | 660 Main Street |
| ZIP | 01801 |
| Phone | 781 245 1325 |
| Website | https://www.biofrontera-us.com |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 84 |
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
Q&A For Biofrontera Stock
What is a current BFRI stock price?
Biofrontera BFRI stock price today per share is 1.5 USD.
How to purchase Biofrontera stock?
You can buy BFRI shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Biofrontera?
The stock symbol or ticker of Biofrontera is BFRI.
Which industry does the Biofrontera company belong to?
The Biofrontera industry is Drug Manufacturers - Specialty & Generic.
How many shares does Biofrontera have in circulation?
The max supply of Biofrontera shares is 14.85M.
What is Biofrontera Price to Earnings Ratio (PE Ratio)?
Biofrontera PE Ratio is now.
What was Biofrontera earnings per share over the trailing 12 months (TTM)?
Biofrontera EPS is -0.43 USD over the trailing 12 months.
Which sector does the Biofrontera company belong to?
The Biofrontera sector is Healthcare.
Biofrontera BFRI included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
26151.3 USD — |
+0.66
|
5.77B USD — | 26034.35 USD — | 26225.83 USD — | — - | 5.77B USD — |
|
US Tech Health Care
IXHC
US
|
1378.46 USD — |
+1.26
|
— — | 1366.6 USD — | 1381.83 USD — | — - | — — |
- {{ link.label }} {{link}}
